Nora Chien Yee Ku

Title: Nora Chien Yee Ku: Innovator in Pharmaceutical Development

Introduction

Nora Chien Yee Ku is a notable inventor based in Woodside, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for serious health conditions. His work focuses on innovative methods of drug administration that aim to improve patient outcomes.

Latest Patents

Nora Chien Yee Ku currently holds a patent for a method of administering doses of a BRUTON'S Tyrosine Kinase Inhibitor. The invention provides a method for using the BTK inhibitor, (S)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-l-(l,l,l-trifluoropropane-2-yl)-lH or a pharmaceutically acceptable salt thereof. This method is particularly relevant for treating conditions such as cancer and autoimmune diseases.

Career Highlights

Throughout his career, Nora has focused on advancing pharmaceutical methodologies. His innovative approach to drug dosing has the potential to enhance therapeutic efficacy and patient safety. Despite having no patents to his name prior to this invention, his work reflects a commitment to improving healthcare solutions.

Collaborations

Nora Chien Yee Ku has collaborated with Nisha Nanda, contributing to the development of his recent patent. Their partnership exemplifies the importance of teamwork in the field of pharmaceutical research and innovation.

Conclusion

Nora Chien Yee Ku is an emerging inventor whose work in pharmaceutical development holds promise for treating complex health issues. His innovative methods and collaborations highlight the ongoing advancements in medical science.